UAE’s Julphar registers USD381.1m revenue in 2014

01 Mar 2015

(MENAFN) UAE’s Julphar registered USD381.1 million revenue in 2014, marking a 5.2 percent increase compared to 2013, Arabian Business reported.

The largest Emirati pharmaceutical company said that sales were motivated by the private market sales which witnessed a 7.5 percent growth with net profit hitting USD63.88 million.

Operational performance also went up with gross profit hitting USD230.86 million, marking a 3.4 percent increase. operating profit reached USD64.91 million.

“2014 was another year of great achievements for Julphar. We are pleased to close the year at USD381.05 million, which shows a remarkable effort from our global sales,” Julphar’s CEO said in a statement.

More News

This website uses cookies to ensure you get the best experience and by clicking “I Accept” below, you consent to the use of cookies. Learn more